Lam’s New CEA-Leti R&D Pact and Dividend Hike Could Be A Game Changer For Lam Research (LRCX)

Simply Wall St

Sat, February 14, 2026 at 4:09 PM GMT+9 3 min read

In this article:

•                                       StockStory Top Pick 
  

  LRCX

  +1.83%

In early February 2026, Lam Research’s board declared a quarterly dividend of US$0.26 per share and announced board and executive leadership changes, while also entering a new multi-year R&D partnership with CEA-Leti to work on specialty semiconductor technologies spanning MEMS, 3D imaging, sensors, RF, photonics, and quantum optics.

Together, these moves signal Lam’s intent to pair ongoing cash returns to shareholders with deeper technology collaboration in areas increasingly linked to AI and high-performance computing demand.

Next, we’ll examine how Lam’s expanded CEA-Leti collaboration in specialty semiconductor R&D could influence its existing AI-focused investment narrative.

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there’s still time to get in early.

Lam Research Investment Narrative Recap

To own Lam Research, you need to believe that AI‑driven chip complexity keeps pulling more spend into Lam’s etch and deposition tools, while cyclical WFE swings and China exposure remain the key near term swing factors. The latest dividend declaration and leadership/R&D updates do not materially change that core thesis, but they can influence how resilient Lam looks if memory or China orders soften in the next downturn.

The new multi year CEA‑Leti collaboration sits closest to this catalyst story, because it targets specialty devices like RF, photonics, and quantum optics that are increasingly tied to AI and high performance computing use cases. If these programs translate into tools that customers adopt at scale, they could deepen Lam’s role in next generation chip manufacturing and partially offset risks tied to customer concentration and WFE cyclicality.

Yet even with these positives, investors still need to think carefully about Lam’s heavy reliance on a small group of big chipmakers and what happens if any one of them…

Read the full narrative on Lam Research (it’s free!)

Lam Research’s narrative projects $23.6 billion revenue and $6.7 billion earnings by 2028. This requires 8.5% yearly revenue growth and about a $1.3 billion earnings increase from $5.4 billion today.

Uncover how Lam Research’s forecasts yield a $204.03 fair value, a 13% downside to its current price.

Exploring Other Perspectives

LRCX 1-Year Stock Price Chart

Some of the most optimistic analysts already expected Lam to reach about US$25.7 billion in revenue and US$7.9 billion in earnings by 2028, so you should treat the new CEA‑Leti work as one more data point that could either support or challenge that much rosier view compared with the more cautious consensus.

Story Continues  

Explore 13 other fair value estimates on Lam Research - why the stock might be worth as much as 38% more than the current price!

Build Your Own Lam Research Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

A great starting point for your Lam Research research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Our free Lam Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lam Research's overall financial health at a glance.

Seeking Other Investments?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.

We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include LRCX.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info